Clinical Trial Update: Artemisinin to Reduce The Symptoms of Schizophrenia [NA]

View source ↗

Summary

An update on a completed clinical trial evaluating artemisinin for reducing symptoms in schizophrenia and schizoaffective disorder; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Artemisinin (Artemisinin)

Snippet

Sponsor: Sheppard Pratt Health System | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED | Results posted: 2012-02-20